SONOMA PHARMACEUTICALS, INC. Derivative, Collateral, Obligation to Return Cash
SONOMA PHARMACEUTICALS, INC. (SNOA) had Derivative, Collateral, Obligation to Return Cash of $37.00 thousand as of 2013-03-31, per its 10-K filed 2013-06-25.
Discontinued › Notes › Offsetting
us-gaap:DerivativeCollateralObligationToReturnCash · last filed 2013-06-25
- 2013-03-31: Derivative, Collateral, Obligation to Return Cash $37.00K.
- 2012-03-31: Derivative, Collateral, Obligation to Return Cash $0.00.
| Period end | Derivative, Collateral, Obligation to Return Cash |
|---|---|
| 2013-03-31 | $37.00K 10-K · filed 2013-06-25 |
| 2012-03-31 | $0.00 10-K · filed 2013-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |